DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Stock Information | RedChip

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) Listen to this Section


$3.60
+0.0900 ( +2.56% ) 15.6K

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Market Data


Open


$3.60

Previous close


$3.51

Volume


15.6K

Market cap


$153.89M

Day range


$3.46 - $3.61

52 week range


$1.94 - $3.81

Insider Ownership Transactions

Total Amount Purchased: -518,113.00 | $ -1,865,206.80

Date Type Amount Purchased Purchaser
2024-06-03 Sale -28472.00 Giuffre Randall Michael
2024-06-03 Sale -130000.00 Wambeke David J.
2024-01-23 Sale -285000.00 Lorianne Masuoka K.
2024-01-02 Sale -9375.00 Semba Charles Pauling
2024-01-02 Sale -14285.00 Kuntz Richard
2024-01-02 Sale -30357.00 Pilnik Richard D.
2024-01-02 Sale -21428.00 Parsons James T.
2024-01-02 Sale -19196.00 Giuffre Randall Michael
2023-11-16 Buy 20000.00 Wambeke David J.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
4 Insider transactions 1 Jun 03, 2024
8-k 8K-related 15 May 23, 2024
8-k 8K-related 16 May 08, 2024
10-q Quarterly Reports 62 May 08, 2024
8-k 8K-related 14 Apr 10, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.